Maastricht Radiation Oncology: Lung Neoplasms trials

The registry lists 32 Lung Neoplasms studies with Maastricht Radiation Oncology as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 1 4Phase 2 7Phase 3 2No phase 19(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• The Effect of 360° Virtual Reality Movies on Fear and AnxietyCompletedNCT06199050Not applicable
• Re-induction of a Systemic Immune Response in Metastatic or Locally Recurrent Lung CancerWithdrawnNCT06024941Phase 2
• ARtificial Intelligence for Gross Tumour vOlume SegmentationActive, not recruitingNCT05775068
• Lung Cancer Organoids and Patient Derived Tumor XenograftsActive, not recruitingNCT05092009
• Prospective Primary Human Lungcancer Organoids to Predict Treatment ResponseCompletedNCT04859166
• 20K Distributed Learning ChallengeCompletedNCT03564457
• Re-Induction After Initial Response With Immune Therapy With Radiotherapy in Lung CancerCompletedNCT03406468Phase 2
• Radiomics to Identify Patients at Risk for Developing Pneumonitis, Differentiate Immune Checkpoint Inhibitor-induced Pneumonitis From Other Lung Inflammation and Distinguish Tumour Pseudo-progression From Real Tumour GrowthCompletedNCT03305380
• DE-CT in Lung Cancer Proton TherapyWithdrawnNCT02844140Not applicable
• Influence of the Use of the Diabetic Drug Metformin on the Overall Survival and Treatment-related Toxicity in Advanced Stage Non-small Cell Lung Cancer Patients.CompletedNCT02109549
• Rapid Learning for Lung CancerCompletedNCT01949259
• Time Trends in Waiting Times of NSCLC Patients.WithdrawnNCT01946490
• Analysis of Treatment Outcome and Toxicity in Non-small Cell Lung Cancer Patients Wither-irradiated to a High Dose for Recurrent DiseaseCompletedNCT01941303
• Usefulness of Blood Biomarkers for Overall Survival in NSCLCCompletedNCT01936571
• SDC for Lung Cancer Patients Treated With Curative Primary or Postoperative Radiotherapy or ChemoradiationCompletedNCT01855191
• Chloroquine as an Anti-autophagic Radiosensitizing Drug in Stage I-III Small Cell Lung CancerTerminatedNCT01575782Phase 1
• Radiomics: a Study of Outcome in Lung CancerCompletedNCT01302626
• Prophylactic Cranial Irradiation (PCI) Cognitive Tests in Non-small Cell Lung Cancer (NSCLC) PatientsCompletedNCT01290809
• Concurrent and Non-concurrent Chemo-radiotherapy or Radiotherapy Alone for Patients With Oligo-metastatic Stage IV Non-small Cell Lung Cancer (NSCLC)CompletedNCT01282450Phase 2
• Prophylactic Cranial Irradiation (PCI) vs Observation in Stage III NSCLCCompletedNCT01282437Phase 3
• Nitroglycerin in Non-small Cell Lung CancerTerminatedNCT01210378Phase 2
• Hypoxia-guided Radiotherapy With Cisplatin-etoposide in Stage I-III : Small Cell Lung Cancer(SCLC)WithdrawnNCT01210131Not applicable
• Adaptive Radiotherapy in Non-small Cell Lung Cancer (NSCLC)CompletedNCT01207063Phase 2
• Concurrent and Non-concurrent Chemo-radiotherapy or Radiotherapy Alone With Intensity-modulated Radiotherapy (IMRT) for Non Small Cell Lung Cancer (NSCLC) to an Individualised Mean Lung Dose (MLD)CompletedNCT01166204Phase 2
• Concurrent Chemo-radiotherapy With Intensity-Modulated Radiation Therapy (IMRT) for Limited Disease Small Cell Lung Cancer (LD-SCLC)CompletedNCT01166191Phase 2
• Chloroquine as an Anti-Autophagy Drug in Stage IV Small Cell Lung Cancer (SCLC) PatientsTerminatedNCT00969306Phase 1
• Radiotherapy for NSCLC to a Individualized MLDCompletedNCT00573040
• Concurrent Chemo-Radiotherapy for Limited Disease Small Cell Lung Cancer (LD-SCLC) on Basis of FDG-PET-ScansCompletedNCT00572923
• Concurrent Chemo-radiation Form NSCLC to a Individualized MLDCompletedNCT00572325
• Phase I Cetuximab and Concurrent Radio-chemotherapyCompletedNCT00522886Phase 1
• Predictive Value of FDG-PET-CT Scans for Patients With Lung Cancer Receiving Concurrent Chemo-RadiationTerminatedNCT00522639Phase 3
• Safety Study of Individualised Radiation Dose Determination for Lung Cancer Patients.CompletedNCT00181545Phase 1